Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS

Part of paid clinical trials in Stony Brook, New York.

Sponsor
Stony Brook University
Study ID
NCT07009691
Status
Recruiting

Conditions

  • Chronic Fatigue Syndrome

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Hydrogen water which is prepared from an OTC supplement. — DIETARY_SUPPLEMENT
    The intervention is hydrogen water which is prepared from an OTC supplement. It involves measurement of heart rate variability.

Study Details

The goal of this clinical trial is to learn if the OTC supplement, hydrogen water, works to treat the fatigue-related symptoms and functional limitations in adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). It will also examine if heart rate variability (HRV) can be used to predict who will benefit from the hydrogen water treatment. The main questions it aims to answer are: Does the OTC supplement, hydrogen water, work to reduce the fatigue-related symptoms and improve functioning in participants who have ME/CFS? Can HRV be used to predict who will benefit from treatment with hydrogen water?

Key Dates

Start date
Jun 9, 2025
Status verified
Jun 2025
Primary completion
May 31, 2026
Completion
May 31, 2026

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Hydrogen water standard dosage
    The intervention is hydrogen water which is prepared from an OTC supplement. Hydrogen water is a strong anti-oxidant.

Primary Outcome Measure

Fatigue Severity Scale [ Time Frame: 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stony Brook UniversityStony BrookNew York11794-8101
Fred Friedberg, PhD
Fred Friedberg, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Stony Brook, NY

Related Studies